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Abstract
Molecular dynamics (MD) simulation allows one to predict the time evolution of a system of interacting particles. It is widely
used in physics, chemistry and biology to address specific questions about the structural properties and dynamical mechan-
isms of model systems. MD earned a great success in genome research, as it proved to be beneficial in sorting pathogenic
from neutral genomic mutations. Considering their computational requirements, simulations are commonly performed on
high performance computing (HPC) devices, which are generally expensive and hard to administer. However, variables like
the software tool used for modeling and simulation or the size of the molecule under investigation might make one hard-
ware type or configuration more advantageous than another or even make the commodity hardware definitely suitable for
MD studies. This work aims to shed lights on this aspect.
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Introduction
Molecular dynamics (MD) simulation is a leading tool of theoret-
ical scientists for the study of the time-dependent motion of
atoms and molecules. It is widely used in physics, chemistry
and biology to confirm hypotheses and to help answering
specific questions about the structural properties and dynam-
ical mechanisms of model systems.
The first simulation of a protein in vacuum was published
by Martin Karplus in 1977 [1], while molecules of water were ex-
plicitly added to the simulation environment only 11 years later
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by Michael Levitt [2]. In 2013, Karplus and Levitt won the Nobel
Prize in Chemistry for their pioneering studies on molecular
models of biological systems. Analogously, nucleic acids were
modeled in vacuum nearly in the same years [3, 4], and in the
more realistic aqueous environment right after [5]. In the fol-
lowing years, another important type of environment was mod-
eled: the lipid bilayer [6, 7], essential to simulate membrane
proteins [8]. Nowadays, size and length of standard MD simula-
tions have grown till tens of millions of atoms and micro/milli-
seconds, even though sporadic examples exist that overcome
these limits [9, 10].
MD earned a great success in biology. Its success was
boosted by the growing availability of genomic information,
such as point mutations, provided by increasingly powerful
next-generation sequencing and microarray-based platforms.
Whole-exome sequencing, among the others, is one of the most
popular high-throughput sequencing strategy. It spans roughly
30 Mb [1], i.e. 30 million nucleotides making the coding part of
the genome. Large population studies conducted on hundreds
of thousands of human exomes taught that about 12–15 000
true single-nucleotide variants (SNVs) can usually be found in
every exome, and that their frequencies may change according
to the ethnical groups.
Irrespective of the rarity (<1% of frequency in a considered
population of individuals, in general) or recurrence of a variant,
the assessment of the physiological effects of coding variants is
currently a matter of debate, especially when these regard the
human being. The first step of this process is the novelty check
in a number of SNVs databases. Historically, the Single
Nucleotide Polymorphism Database (dbSNP) [11] is the reference
repository. Hundreds of independent institutions or consortia
stably feed dbSNP with variants of different types (e.g. SNVs,
short indels and microsatellites). The consequence is that >150
million variants are currently recorded in dbSNP ver. 149. This
number is intended to rapidly grow. Similar databases exist:
ESP, containing data of 6500 exomes (NHLBI Exome
Sequencing Project, Seattle, WA; accessed on August 2016),
Exome Aggregation Consortium, with 65 000 exomes
(Cambridge, MA; accessed on August 2016), Kaviar Genomic
Variant Database, with 64 000 exomes (accessed on August
2016) [12], and the Haplotype Reference Consortium, with
65 000 haplotypes (accessed on August 2016). Generally, but
not absolutely, only novel or low-frequent variants are con-
sidered as candidate disease-causing mutations. These are usu-
ally still too many to be all validated in vitro or in vivo and, then,
their number needs to be further purged of low-priority
variants.
Numerous scientists devoted a significant portion of their
research to design new algorithms and to develop new tools
capable of sorting mutations by their harmfulness. This task
was mainly pursued by algorithms borrowed from comparative
genomics, structural biology, molecular evolution, biochemis-
try, cell physiology and pharmacology. These accounted for in-
formation like the sequence alignments, peptide ternary or
quaternary structures, biochemical properties of molecules,
their evolutionary dynamics and sequence conservation
through species, to calculate, on-the-fly, the pathogenicity
scores of genomic mutations. Dozens of such software packages
exist. A few others added the possibility to browse or download
precomputed estimations of pathogenicity of all human nuclear
[13] and mitochondrial [14] non-synonymous and splice-site
variants. Unfortunately, it is common knowledge that none of
them correctly predicts the pathogenicity of all variants ana-
lyzed in any considered context. Surprisingly, even permuting
the results of any subset of software does not increase the de-
tection sensitivity over the top performer alone [15].
The generally suboptimal performance of these predictors
pushed the development of other tools that were based on
structural and functional considerations. These can be grouped
into three subcategories: those that base their predictions on
structural information, like Struct2Net [16]; those that base on
domain information, available from, e.g. Pfam [17] or Uniprot
[18], and on protein interaction evidences, like STRING [19];
those that simulate the temporal trajectories or dynamics of the
constituting particles of molecular models. Irrespective of the
ways a molecular model is obtained, this last category makes
use of two distinct classes of methods.
The classical MD methods process molecules as if they were
elementary objects, like soft balls, which represent atoms, and
elastic sticks that join pairs of atoms. The Newton’s second law
rules their overall dynamics. From the knowledge of the initial
positions, velocities and individual forces of the atoms in the
system, it is possible to calculate their trajectories, namely, the
variation over time of their positions, velocities and acceler-
ations. Quantum MD is a significant evolution of the classical
MD. It focuses on the interactions between atoms and electrons
only, without resorting to experimental data, and accounts for
forces that are inferred by theoretical calculations of the elec-
tronic structures and that make the system’s dynamics evolve
over time. Quantum MD was successfully used to tackle several
biological issues [20, 21], although it is known to suffer from the
important drawback of being highly computational demanding.
For this reason, the considered models are usually much simpli-
fied or, simply, naturally small. Additionally, hybrid quantum
mechanics/molecular mechanics simulations were introduced
to model complex systems, while keeping the number of quan-
tum mechanical variables at a minimum. A limit of this ap-
proach is the choice of the QM region [22], while it is
advantageous when chemical reactions are involved. The bal-
ance between advantages and detail loss pushed scientists to
make preponderantly use of classical MD over the two.
In this perspective, we focus on tools that implement the
classical MD methods and will apply some representatives on
official benchmark models and on (un)conventional hardware
equipments. These are real-life models, as they come from on-
going research projects or published articles, and differ in size
(small, medium and large) and molecules type (protein, RNA
and lipids). The aim is to help researchers to assess the feasibil-
ity of their MD analyses with the hardware in hand, as well as
to make decisions on which hardware to acquire to get the best
compromise in terms of cost/performance.
The MD workflow
A standard MD workflow (Figure 1) starts from the selection of a
three-dimensional (3D) model, which sticks particle names to
3D coordinates. Depending on the availability of high-resolution
experimental data from X-ray crystallography or nuclear mag-
netic resonance experiments, which are usually stored in the
Protein Data Bank (PDB) [23], this step can be simple or really
harsh. Resolution is not the only factor to consider when choos-
ing a starting model of a system. The presence and length of un-
resolved loops, for example, can strongly undermine the
goodness of a model.
In the unfortunate case when a model is not available, this is
usually inferred by means of two different categories of predic-
tion methods: homology [24, 25] and ab initio [26, 27] modeling.
The former builds a target model referring to a second
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homologous protein as a template. It can be subclassified in
homology modeling (or comparative modeling) and protein
threading (or fold recognition). Both are template-based meth-
ods, and there are no rigorous boundaries between them in
terms of prediction techniques. The former is used whenever
homologous proteins of targets are available. Protein threading
is used when only a fold-level homology is found. This operat-
ing logic is implemented in several software packages:
MODELLER [28], I-TASSER (Iterative Threading ASSEmbly
Refinement) [29], SWISS-MODEL [30], Phyre2 [31] and MOE
(Molecular Operating Environment) (Web address: https://www.
chemcomp.com/MOE-Molecular_Operating_Environment.htm).
Ab initio modeling is usually opted for whenever even a tem-
plate is not available. In this case, a model is built de-novo ac-
cording to physical laws rather than solved structures.
Generally, these last methods are highly computational de-
manding and are, thus, used to simulate small proteins.
Relevant representative softwares are QUARK [32] and ROSETTA
[33].
Once obtained the 3D structure, the next step is that of creat-
ing a virtual box containing the molecule of interest. Often, the
box is filled of solvent and ions, at a specified concentration,
with the aim to mimic the total charge of the environment and,
eventually, to neutralize it. Ions are approximated as charged
point particles and do not possess more detailed electronic
structures, which might be relevant for ion-binding sites and
transition metals ligated to proteins. However, when using the
NaCl molecule, a simple point charge representation is usually
sufficient.
Coordinates of the starting model, together with the atoms
constituting solvent and ions and with force fields, make the
topology of a system. A force field is defined by a mathematical
expression that describes the structural properties and vibra-
tional spectra of a system. Force fields are obtained by parame-
terizing the potential functions from ab initio or semiempirical
quantum mechanical calculations or by experimental data.
Force fields for classical MD, even when obtained by QM calcula-
tions, are not physical quantities. Therefore, a force field is only
valid for a molecule in the framework for which it was de-
veloped, and its reliability should be evaluated based on the re-
producibility of experimental data.
A topology file defines which atom is connected with which
other and through which kind of chemical bond. Thus, the final
topology of a system defines bonds between two atoms, angles
among three and dihedrals, when four atoms define an angle
between two intersecting planes.
Figure 1. MD workflow.
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Once defined the topology, a minimization step requires
finding an arrangement of the atoms in space that guarantees
that the net interatomic forces acting on each particle are as
close to zero as possible. The actual aim of this step is to find
the closest local, thus not global, minimum energy configur-
ation. To reach a minimum, the system must undergo several
iteration cycles, in the order of thousands, where coordinates of
atoms are iteratively updated until convergence. Each iteration
is also known as a minimization step. There are three major
protocols for minimization: steepest descent [34], conjugate gra-
dient [35] and Newton–Raphson [36]. The former method is
computationally inefficient, although it is deemed robust and
reliable. It is commonly used during the first iteration cycles
when the model is far from the minimum configuration. The se-
cond method uses information from previous iterations to de-
termine the currently optimal direction toward the minimum.
The reiteration of this procedure causes a drastic improvement
in performance near the minimum. The latter method assumes
parabolic potential energy, and in the ideal case where all po-
tentials are exactly parabolic, it determines the minimum in a
single step. The computational improvement is dramatic near
the minimum, but when systems are far from the minimum,
the algorithm could diverge toward high-energy structures.
A minimized system undergoes equilibration. This stage is
required because the input structure is typically not within the
equilibrium phase space of the simulation conditions. For a few
iterations, the system is weakly coupled to a heath bath, i.e. a
system of unlimited thermal capacity, in which the temperature
remains constantly in contact with the system of interest,
whose temperature is gradually increased until reaching the
desired value. Given a typical time step of 1 fs, the equilibration
step lasts at least 5 ps (5000 time steps), but more frequently 10
or 20 ps.
The dynamics of a model is here ready to be simulated. The
classical name of this step is production dynamics (Figure 1). We
will particularly focus on this task the hereafter.
Materials and methods
MD software
This study made use of Amber 16 [37], NAMD version 2.11 [38]
and GROMACS 5.1.2 [39] for the production dynamics step, as
they are the most used tools in the analysis of biomolecular
systems.
The Amber Molecular Dynamics Package includes different
software modules that allow to set up, perform and analyze MD
simulations. The name Amber refers to a family of classical
force fields of natural biomolecules and to the software tools de-
signed to parameterize nonstandard complex molecules.
Amber runs on the most widely used Unix platforms and com-
pilers and is written in Fortran 90 and C languages. Today, it is
distributed in two parts: Ambertools and Amber. The former is
free of charge, and its components are mostly released under
the GNU General Public License (GPL). Amber is available under
a Site License Agreement, which includes the source code, cur-
rently priced at US $500 for noncommercial and US $20 000 for
commercial organizations. One of the main programs included
in Amber is LEaP. This takes in input force fields and atom co-
ordinates as PDB files (.pdb), to produce the files necessary for
the preparation of the topology. There are two versions of this
program, a graphical interface called xleap and a command-line
version called tleap. Amber consists of three MD simulation
tools: Sander, Pmemd and Pmemd.cuda. Sander is the central
parallel simulation program and provides algorithms for energy
minimization and MD; PMEMD is a re-implementation of
Sander, which minimizes the exchange of data between proces-
sors and thus performs better if used in parallel by >8–16 com-
puting processors; Pmemd.cuda is an extension of the Fortran
implementation of PMEMD, with calls to specific CUDA kernels
for graphics processing unit (GPU) acceleration.
NAMD is a parallel MD software developed using the
Charmþþ parallel programming model. It is known to simulate
large systems, in the order of millions of particles, efficiently.
Source code and binaries are available freely for noncommercial
purposes. It makes use of the psfgen plug-in to build topologies
starting from PDB input files. NAMD works with the force fields
of Amber and CHARMM and ‘understands’ their parameters and
file formats. It is coupled with the molecular graphics program
VMD, which provides tools tailored to NAMD, in addition to
standard visualization functions. NAMD and VMD use GPUs to
accelerate many computationally demanding functions.
GROMACS is a free, open-source MD software package, de-
signed for the simulation of proteins, lipids and nucleic acids. It
is released under the GNU LGPL since version 4.6. It is equipped
with a rich library of trajectory analysis tools and scripts for the
conversion of input file formats. It supports a variety of force
fields and is known for its extreme flexibility and versatility.
GROMACS can be executed in parallel on central processing unit
(CPUs) and GPUs using the Message Passing Interface (MPI)
or threads. Since version 4.6, all available compute resources
can be exploited by a hybrid acceleration method that
allows the use of multiple CPUs and GPUs, simultaneously.
Under a non-GPL license, GROMACS is used in the
Folding@home distributed computing project for the simulation
of protein folding.
Biomolecular benchmark systems
Each MD tool was used to analyze three test cases, which
mainly differed by size, i.e. atoms count, and molecular type.
The smallest system (60 000 atoms) is a protein, named
SUFU negative regulator of hedgehog signaling, which is bound
in PDB to a member of the GLI family zinc finger (PDB ID: 4BLD;
[40]; Figure 2A). The system was modeled from scratch following
the steps described in the workflow in Figure 1 and simulated
with the three MD tools. In detail, the topology of this system
was built using Amber tleap. The resulting model was
embedded in a box, extending up to 12 A˚ and solvated using the
TIP3P water model. tleap was also used to add counter ions and
thus to neutralize the overall charge of the model. The topology,
consisting of 59 140 atoms, was suitable also for NAMD, being
this compatible with the topology file formats generated by
Amber. We needed, instead, to build a dedicated topology for
GROMACS. To do that, we followed the workflow described in
Supplementary File 1. The resulting topology was made up of
60 852 atoms. Both topologies of the small system were firstly
energy minimized, then equilibrated for 5 ns, by a time step of
1 fs. Finally, the equilibrated systems were simulated for 50 ps,
by a time step of 2 fs (25 000 steps).
Medium (100 000 atoms) and large (1 000 000 atoms) sys-
tems were chosen instead, among the benchmark models, al-
ready minimized and equilibrated, available from the Web sites
of the considered MD tools.
The selected medium systems were (i) one of the serine pro-
teases of the coagulation system, the Factor IX protein NPT (iso-
thermal–isobaric ensemble) in TIP3P water (90 906 atoms) for
Amber (Figure 2C); (ii) the apolipoprotein A-I, which is the
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primary protein constituent of HDL, solvated in explicit water
(92 224 atoms) for NAMD (Figure 2B); (iii) the hydrated mixed 1,2-
dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) bilayer lipid
(121 856 atoms), downloaded from ftp://ftp.gromacs.org/pub/
benchmarks/gmxbench-3.0.tar.gz, for GROMACS (Figure 2D).
The large system was the satellite tobacco mosaic virus
(STMV) for all three MD tools. The Amber model was made of
1 067 095 atoms and taken from http://ambermd.org/Amber16_
Benchmark_Suite.tar.bz2. The NAMD model (1 066 628 atoms)
was downloaded from http://www.ks.uiuc.edu/Research/namd/
performance.html. The GROMACS topology was retrieved from
[41] and included 30 proteins (i.e. half a STMV capsid) and some
RNA fragments. Initial coordinates were taken from PDB (PDB
ID: 1A34). The model was solvated in 275 415 molecules of
water, 887 Naþand 827 Cl. The total number of atoms was
914 499 (Figure 2E). Nonbonded settings for all systems were set
to be comparable, as specified in the Supplementary File 2.
Measures of performance
For each system, we measured the wall-clock time (WCT), i.e.
the amount of elapsed time at task completion. For each sys-
tem, the WCT of the slowest simulation of all performed simu-
lations on CPU and GPU and on any number of computing CPU
cores/GPUs, was called tslowest. The WCT obtained by N comput-
ing CPU cores or GPUs was specified as tN. We plotted speedup-
like charts (here referred to as speedup for simplicity), according
to the formula tslowest=tN.
Computational resources
MD simulations were run on a cluster of three computing nodes,
each equipped with 4 AMD OpteronVR processor 6172 @2.1GHz,
with 12 CPU cores and 256 GB of RAM, for 144 working cores. Nodes
are interconnected over InfiniBand through Mellanox/Intel host
bus adapters and network switches. MD simulations were also run
Figure 2. 3D structure of (A) human suppressor of fused (SUFU)-GLI3p complex, (B) factor IX protein, (C) apolipoprotein A-I, (D) hydrated mixed DPPC bilayer lipid and
(E) STMV generated with UCSF Chimera.
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on a 2X Intel Xeon E5620 @2.40GHz workstation (2 processors, 4
computing cores and 16 threads, with hyper-threading enabled),
equipped with 12 GB of RAM and 4NVIDIA Tesla C2070 GPUs.
To make this study repeatable, command lines, parameters
and configuration files were made available in Supplementary
File 2.
Results
Production dynamics performance
Each system was simulated three times. WCTs varied <5%
through each triplet. All benchmarks presented here refer to the
best of the three, in terms of WCTs. Simulations were run on 1–
144 AMD CPU cores, as well as on 1–16 CPU cores of an Intel
workstation (hyper-threading enabled) and from one to four
GPUs. The slowest simulation, i.e. tslowest, was achieved by
Amber with the small and large systems and by NAMD with the
medium system, when simulating each system with one AMD
computing core.
Although the benchmark systems were carefully chosen and
analyzed by state-of-the-art methods, a detailed comparison of
the performance of these MD tools was not only out of our scope,
but in this case, not even possible in a rigorous manner. All con-
siderations reported in the paragraphs below concern commodity
hardware, which was intentionally chosen for this study. High-
cost and more performing hardware could overturn our results.
Furthermore, important biases may also originate from the differ-
ent molecular types of the medium systems, as well as from the
fact that each tool supports some specific features that are not
provided by the others as, for example, the way to integrate the
time steps and to control the temperature and pressure. The only
two variables considered in this work are the size of the systems
(small, medium and large), and the size and type of processing
units [small to medium sized conventional (CPU) or unconven-
tional (GPU) hardware architectures]. With this in mind, we rea-
soned in terms of scalability of one over the other.
CPU-based computation
Figure 3 reports speedups for small (A), medium (B) and large
systems (C), relative to the simulation runs on CPU cores.
GROMACS was the best performer on a single core with the
small (3.57), medium (2.62) and large (3.16) systems, as well
as on all other CPU configurations. The serial execution of
NAMD run faster than that of Amber for the small and large sys-
tems and was the slowest for the medium system. The speedup
of Amber grew up until 96 and 128 cores, significantly, with the
small and medium system, before reaching a plateau. For the
large system, a plateau was reached earlier with 24 cores.
The NAMD code confirmed to be at ease with large systems
run on big HPC infrastructures. It is not surprising, in fact, that
NAMD did not perform as well with the small system as it did
with the large one. It continued scaling until 144 cores and po-
tentially even more with the addition of further CPU cores. The
speedup with the small system increased until 48 cores, before
stopping scaling soon later. However, performance slightly im-
proved until 128 cores and definitely decreased with 144 cores.
GPU-based computation
The same systems were simulated on a GPU- and Intel CPU-
equipped workstation with hyper-threading enabled, i.e. able to
spawn until 16 parallel tasks. GPU cards were set up to commu-
nicate by MPI, and one MPI process was systematically mapped
to one GPU. Figure 4 reports speedup values for small (A), me-
dium (B) and large (C) systems. Amber performed best with all
three systems, regardless of the number of GPUs used. The best
Figure 3. Speedup plots for the small (A), medium (B) and large (C) systems
simulated on CPU nodes. Amber with dotted line, NAMD with dashed line and
GROMACS with plain line.
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performance was achieved with two GPUs with the medium
system (131.49X). The use of the other two was penalizing be-
cause the motherboard hosting the four GPU cards only allows a
two-way peer-to-peer communication at full 16 speed. The
speedup achieved with only one GPU outperformed systematic-
ally the best records of the other tools obtained with any other
configuration and with any system. GROMACS stopped scaling
when run on more than two GPUs, and reached a seamless
Figure 4. Speedup plots for the small (A), medium (B) and large (C) systems simulated on GPU nodes and mapping one MPI process to one GPU. Small (D), medium (E)
and large (F) systems simulated on GPU nodes with optimization enabled for NAMD and GROMACS. Amber with dotted line, NAMD with dashed line and GROMACS
with plain line.
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plateau. NAMD, instead, scaled constantly, as already verified
with the CPUs.
GROMACS and NAMD provide also some optimization op-
tions that better exploit the GPUs when they are underused. In
detail, NAMD is able to map MPI processes to multiple CPU
cores, and thus to process several GPU kernels on the same
GPU, concurrently. GROMACS further allows hybrid parallelism,
namely it can delegate the computation of the OpenMP multi-
threaded bonded forces and PME long-range electrostatic calcu-
lations to the CPU cores, while dealing with all nonbonded
forces by the GPUs. Amber just uses a single core per GPU and
does not provide any optimization strategy.
Figure 4D–F reports benchmarks for the same systems, with
optimization enabled for GROMACS and NAMD. The values re-
ported for these two tools represent the best speedups achieved
with the best combination of number of threads and GPUs.
GROMACS inspected the hardware available at run time and did
its best to make fairly efficient use of the whole node. NAMD
was finely tuned, and, generally, it obtained the best perform-
ance with the maximum available threads (cf. Table 1).
These plots confirm that the optimization strategies were
generally beneficial. In terms of scalability, GROMACS achieved
the best performance with four GPUs and with the large system.
Amber continued to be the best with only two GPUs and with
the medium system. NAMD was generally slower than the
others, obtaining its best performance (speedup of 72.44 for the
small system, 84.23 and 106.49 for the medium and large sys-
tems, respectively) when exploiting all available hardware com-
ponents, i.e. 16 threads and 4 GPUs (eight threads and four GPUs
with the small system).
OpenCL versus CUDA
We have compared CUDA with an alternative general-purpose
parallel programming paradigm, OpenCL, on our systems. To
this end, we have ran GROMACS, which supports both para-
digms, on the small, medium and large systems, using one to
four GPUs. As expected, all simulations performed well with the
CUDA compiled version of GROMACS that exhibited systematic
lower WCTs as compared with those obtained with the OpenCL
compiled counterpart. The benchmark data are reported in
Table 2. In particular, CUDA simulations run 1.2–1.5 times faster
than the OpenCL ones for all systems. This is mainly due to the
different implementations of the off-load computation of the
forces and energies that are generally more efficient on CUDA-
based kernels.
AMD versus Intel
After disabling the hyper-threading on the GPU workstation, we
directly compared the performance of AMD and Intel proces-
sors. In detail, all simulations were performed using one, two,
four and eight CPU cores. All MD codes were generally run more
efficiently on the Intel hardware, thereby exhibiting a speedup
increase that ranged from 1.37 to 2.18, as compared with the
AMD WCTs (Supplementary Table S1).
DISCUSSION
Our results suggest that Amber performs differently on CPU and
GPU. Its performance is in line with those of GROMACS and
NAMD, when run on devices with low core counts, like common
workstations. However, its speedup is lower than that of the
other codes. Instead, it greatly benefits from the GPU acceler-
ation. It is interesting to note that the best speedup obtained
with the CPU cores by Amber was exceeded with only one GPU
for all three systems. Two GPUs working together made Amber
the best performer with the medium system and the second
best with the small and large systems. The use of additional
two GPUs did not contribute to the increase of the speedups. As
anticipated, this is mainly due to the fact that Amber 16 uses
peer-to-peer communication to provide optimal multi-GPU
scaling, and no standard motherboards exist that support more
than two-way peer-to-peer at full 16 speed, included our
Table 1. WCTs obtained with NAMD, with multi-threading enabled
HW configuration Small system Medium system Large system
1 GPU
1 thread 2283.94 2856.59 31 901.20
2 threads 1162.26 1548.38 15 563.51
4 threads 669.36 821.65 8850.89
8 threads 486.51 650.86 7365.68
16 threads 513.27 669.05 7 618 89
2 GPUs
2 threads 1169.16 1550.55 15 710.72
4 threads 637.22 805.01 8404.94
8 threads 402.43 489.83 5242.70
16 threads 378.13 409.34 4703.44
3 GPUs
3 threads 851.30 1073.30 11 132.77
6 threads 485.15 584.28 6339.45
12 threads 470.80 567.95 5653.58
15 threads 404.42 435.77 4754.21
4 GPUs
4 threads 640.76 794.65 8464.19
8 threads 395.24 475.96 5025.46
16 threads 388.05 398.47 4512.60
Note. WCTs are expressed in seconds. The best performances are highlighted in bold.
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workstation. The Amber team faced this issue in collaboration
with the Exxact Corporation. They designed a hardware solu-
tion that hosted up to 10 GPUs on a single PCI Express root hub.
This allowed the GPUs to communicate with each other without
having to pass through the CPU chipset, thereby reducing the
communication latency. The PCI Express is then reserved to I/O
operations only. With this setting, the best possible perform-
ance can be achieved when running different jobs on different
GPUs. Another important advantage of this configuration is that
the computing performance on GPU is not more constrained by
the CPU characteristics and, then, even commodity hardware
hosting GPU cards can be exploited. A more obvious, but not
less important, benefit is that all individual calculations run on
as many GPUs can be run without interfering with each other’s
performance.
The scalability of NAMD on CPU cores was higher on the large
systems. However, its performance improved significantly with
the use of more CPU cores. NAMD benefited of the use of GPU ac-
celerators, especially when each GPU was shared by multiple CPU
cores. In this setting, NAMD automatically and equally distributed
threads among the available GPUs on a node. All three systems
were simulated faster when eight threads were spawned for one
GPU. When using more than one GPU, the optimal solution was
that of spawning all available threads, i.e. 16. The speedup of
NAMD obtained with four GPUs was in line with that obtained
with 48 CPU cores on all three systems and was achieved with all
four GPUs working together, when one process was mapped to any
one GPU. Mapping all available processes to the GPUs made the
performances to exceed those obtained with 144 CPUs. The results
of this study is that NAMD may greatly benefit from modern tech-
nology and that its scalability is good up to the maximum number
of nodes. This is confirmed by some official benchmarks available
at http://www.hpc.cineca.it/content/namd-benchmark where the
maximum number of CPU cores is 2000.
GROMACS shined for its extremely high scalability capacity
with all systems on CPU cores. On the other hand, it did not
stand out when run on GPUs. For example, the speedups
achieved by four GPUs with all systems were close to those ob-
tained with 48 CPU cores and even lower than those obtained
with 96, 128 and 144 CPU cores. Its hybrid parallel configuration
(OpenMP/MPI) performed systematically better than the single-
threaded setup. However, this should not be considered as a
rule of thumb. The fact that the hybrid configuration allowed
GROMACS to efficiently distribute the computational work on
the CPU cores used in this study might not be always true, as
MPI and OpenMP might exhibit different parallel scaling behav-
iors on other hardware infrastructures and MD systems.
Take-homemessages
Amber is generally a good choice for the simulation of small/
medium systems and particularly when only commodity hard-
ware is available or when the hardware resources are limited.
The use of one, or better, two GPUs generally allows achieving
high performances.
GROMACS behaves well on small systems, when run on
GPUs. However, it excels with big systems when high numbers
of CPU cores are available.
NAMD is the second-best option when running on CPUs. It is
the leader in flexibility, as it ‘understands’ all available topology
file formats. Contrary to Amber, it seems to benefit from mod-
ern CPU computing technology and to significantly improve its
performance on devices equipped with high numbers of CPUs.
Key Points
• The assessment of the putative pathogenicity of gen-
omic mutations is a critical task.
• Dozens of software packages exist that predict the pu-
tative pathogenicity of genomic variants.
• MD simulation is a leading tool of theoretical scien-
tists for the study of the time-dependent motion of
atoms and molecules.
• GPU computing is the use of GPUs together with CPUs
to accelerate domain-specific applications.
• MD simulations are run on GPU or CPU hardware for
the discovery of harmful mutations.
Supplementary Data
Supplementary data are available online at http://bib.oxford
journals.org/.
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